TA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
every week it's next week
LOL
No one will buy that new spin
Its 30 day from the 11th
If no FDA news before the open then we all knows if u like it or not it wasn't approved
positive.
December 09, 2009
--30 day timeframe from last submission (label info) is up shortly.
why r u changing the story now?
partied last night with 2 buddies who bought IMGG with me about 6 years ago. gotta say the vibe was good! here's to next week.
Party on the FDA non approval? or missing the dead line?
We all agree on on that
Now what?
We are still working with the FDA. I'll fill you in with progress once I have something concrete to tell you. I really can't elaborate as I don't want to inhibit any ongoing aspects of the process.
January 12, 2009
Dean
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34746253
When was it the last time that the SEC did approve the SH meeting for IMGG?
Anybody?
No one will touch a co that has open issue with the SEC for more than 12 month now with a 10 foot pole
Why the SEC is refusing to let IMGG proxy for more then a year now?
Filing Date: 11/5/2008 Form Type: PRE 14A
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001065949%2D08%2D000223%2Etxt&FilePath=%5C2008%5C11%5C05%5C&CoName=IMAGING3+INC&FormType=PRE+14A&RcvdDate=11%2F5%2F2008&pdf=
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934
Filed by the Registrant X
Filed by a Party other than the Registrant /_/
Check the appropriate box:
X Preliminary Proxy Statement _ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) _ Definitive Proxy Statement _ Definitive Additional Materials _ Soliciting Material Pursuant to ss.240.14a-12
IMAGING3, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
_ No fee required.
_ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
_ Fee paid previously with preliminary materials.
_ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
-1-
--------------------------------------------------------------------------------
IMAGING3, INC.
3200 W. VALHALLA DRIVE
BURBANK, CALIFORNIA 91505
NOVEMBER 5, 2008
Dear Shareholder:
The Board of Directors of Imaging3, Inc. (the "Company") has approved an amendment to the Company's Articles of Incorporation in order to increase the number of authorized shares of common stock from 500,000,000 to 750,000,000, par value $0.001 per share and to authorize 1,000,000 shares of preferred stock, par value $0.001 per share. The Board of Directors is also recommending an amendment to the Company's Bylaws to increase the size of the Company's Board of Directors from two (2) to a range of five (5) to nine (9), with the exact number of directors to be seven (7).
The Board's action to amend the Articles of Incorporation and the amendment to the Company's Bylaws are subject to the approval of the Company's shareholders.
The Board of Directors considers the increase in authorized shares desirable to provide maximum flexibility with respect to the Company's ability to augment its capital in the near future, and to provide greater flexibility for declaration of stock dividends and for other proper corporate purposes in the long term. The Board of Directors believes that increasing the size of the Company's Board of Directors is necessary to allow the Company to add additional advisors to the Board of Directors, including advisors who are independent as defined in Rule 4200 of Financial Industry Regulatory Authority's listing standards. We urge you to read the accompanying written consent solicitation carefully, as it contains a detailed explanation of the proposed amendment and the reasons for the proposed amendments. The Board of Directors believes the proposed amendments are in the best interest of the Company and its shareholders.
Please complete, date and sign the enclosed written consent solicitation and return it promptly in the enclosed envelope on or before December 9, 2008 to ensure that your vote is counted with respect to the proposed amendments to the Company's Articles of Incorporation and Bylaws.
Sincerely,
Dean Janes, Chief Executive Officer and Chairman of the Board
--------------------------------------------------------------------------------
IMAGING3, INC.
3200 W. VALHALLA DRIVE
BURBANK, CALIFORNIA 91505
NOVEMBER 5, 2008
CONSENT SOLICITATION STATEMENT
This Consent Statement is being furnished in connection with the solicitation of written consents of the shareholders of Imaging3, Inc. (the "Company," "we," "us" and "our") to amend our Articles of Incorporation and Bylaws. The proposed amendment to our Articles of Incorporation (the "Articles Amendment") would increase the number of shares of our authorized common stock from 500,000,000 to 750,000,000 shares, par value $0.001 per share, and to authorize 1,000,000 shares of preferred stock, par value $0.001 per share as discussed further herein. The proposed amendment to our Bylaws would increase the size of our Board of Directors from two (2) to a range of five (5) to nine
(9), with the exact number of directors to be seven (7).
We intend to mail this Consent Solicitation Statement and the accompanying consent card on or about November 19, 2008 to the holders of record of our common stock as of the close of business on October 31, 2008. This date is referred to as the "record date." Written consents of shareholders representing a majority of the voting power of our common stock on the record date are required to approve the Amendment.
GENERAL
The Board of Directors has elected to obtain shareholder approval of the Articles Amendment and Bylaws Amendment by written consent, rather than by calling a special meeting of shareholders. Written consents are being solicited from all of our shareholders pursuant to Section 603 of the Corporations Code and Section 10 of Article II of our Bylaws.
RECEIPT OF CONSENTS
We must receive your written consent by 5:00 p.m., Pacific Time, on December 9, 2008 (unless extended by us) (the "Approval Date") to be counted in the vote on the Amendment.
Shareholders who wish to vote "YES" for the Articles Amendment and Bylaws Amendment (collectively, the "Amendment") should complete, sign and date the accompanying written consent card and return it to us in the enclosed postage prepaid envelope as soon as possible.
A written consent card returned by a shareholder will be counted "consent to," "does not consent to" or "abstain" with respect to the Amendment, as indicated on the consent card, with respect to all shares shown on the books of the Company as of the record date as being owned by such shareholder. ANY SHAREHOLDER WHO SIGNS AND RETURNS THE WRITTEN CONSENT CARD BUT WHO DOES NOT INDICATE A CHOICE THEREON WILL BE DEEMED TO HAVE CONSENTED TO THE APPROVAL OF THE AMENDMENT. Shareholder approval will be effective upon receipt by us of affirmative written consents representing a majority of the Company's outstanding shares, but in no event prior to December 9, 2008.
WHO MAY VOTE
Only shareholders of record as of the record date of October 31, 2008 may vote. You are entitled to one vote for each share of the Company's common stock you held on the record date.
-1-
--------------------------------------------------------------------------------
There were 248,924,052 shares of the Company's common stock issued and outstanding on the record date. The Company has no other class of capital stock outstanding. Consent may be given by any person in whose name shares stand on the books of the Company as of the record date, or by his or her duly authorized agent.
IF YOU HOLD YOUR STOCK IN "STREET NAME" AND YOU FAIL TO INSTRUCT YOUR BROKER OR NOMINEE AS TO HOW TO VOTE YOUR SHARES, YOUR BROKER OR NOMINEE MAY NOT, PURSUANT TO APPLICABLE STOCK EXCHANGE RULES, VOTE YOUR STOCK WITH RESPECT TO THE AMENDMENT.
VOTE REQUIRED
WE MUST RECEIVE WRITTEN CONSENTS REPRESENTING A MAJORITY OF THE OUTSTANDING SHARES OF OUR COMMON STOCK FOR APPROVAL OF THE AMENDMENT. Accordingly, abstentions from voting will have the effect of a vote "against" the Amendment.
REVOCATION OF CONSENT
You may withdraw or change your written consent before the solicitation period expires (December 9, 2008). You will need to send a letter to the Company's corporate secretary stating that you are revoking your previous vote.
ABSENCE OF APPRAISAL RIGHTS
Shareholders who abstain from consenting with respect to the Amendment, or who withhold consent to the Amendment, do not have the right to an appraisal of their shares of common stock or any similar dissenters' rights under applicable law.
EXPENSES OF THIS SOLICITATION
This solicitation is being made by the Board of Directors of the Company, and we will bear the costs of such solicitation, including preparation, printing and mailing costs. Written consents will be solicited principally through the mails, but our directors, officers and employees may solicit written consents personally or by telephone. Arrangements will be made with brokerage firms and other custodians, nominees and fiduciaries to forward these consent solicitation materials to shareholders whose stock in the Company is held of record by such entities, and we will reimburse such brokerage firms, custodians, nominees and fiduciaries for reasonable out-of-pocket expenses incurred by them in connection therewith. In addition, we may pay for and utilize the services of individuals or companies we do not regularly employ in connection with this consent solicitation, if management determines it advisable.
-2-
--------------------------------------------------------------------------------
PROPOSALS TO BE VOTED ON
PROPOSAL NO. 1
AMENDMENT TO ARTICLES OF INCORPORATION
As described in the accompanying CONSENT SOLICITATION STATEMENT, the Company proposes to amend its Articles of Incorporation in order to increase the number of authorized shares of the Company's common stock from 500,000,000 to 750,000,000, par value $0.001 per share, and to authorize 1,000,000 shares of preferred stock, par value $0.001 per share (the "Articles Amendment").
The Board of Directors of the Company voted unanimously to implement the Articles Amendment because the Board of Directors believes that increasing the size of the Company's Board of Directors is necessary to allow the Company to add additional advisors to the Board of Directors, including advisors who are independent as defined in Rule 4200 of Financial Industry Regulatory Authority's listing standards.
The Board of Directors believes that an increase to the number of authorized shares of the Company's common stock and the authorization of shares of preferred stock will allow the Company to raise the capital necessary for the Company to grow its business in the future.
The Company is not expected to experience a material tax consequence as a result of the Articles Amendment. Increasing the number of authorized shares of the Company's common stock, and authorizing preferred stock may, however, subject the Company's existing shareholders to future dilution of their ownership and voting power in the Company.
POTENTIAL ANTI-TAKEOVER EFFECT
The additional shares of common stock and preferred stock that would become available for issuance if the proposal were adopted could also be used by the Company to oppose a hostile takeover attempt or delay or prevent changes in control or management of the Company. For example, without further stockholder approval, the Board could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board. Although this proposal to increase the authorized common stock and to authorize preferred stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at the Company), nevertheless, stockholders should be aware that approval of this Proposal No. 1 could facilitate future efforts by the Company to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for their shares over then current market prices.
VOTE REQUIRED AND BOARD RECOMMENDATION
Approval of the Articles Amendment requires the affirmative written consent of shareholders holding at least a majority of the Company's outstanding common stock. The directors and executive officers of the Company, holding an aggregate of 97,339,955 voting shares or 39% of our common stock as of October 31, 2008, intend to vote FOR approval of the Amendment.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE COMPANY
GIVE THEIR WRITTEN CONSENT IN FAVOR OF THE ARTICLES AMENDMENT.
-3-
--------------------------------------------------------------------------------
PROPOSALS TO BE VOTED ON
PROPOSAL NO. 2
AMENDMENT TO BYLAWS
As described in the accompanying CONSENT SOLICITATION STATEMENT, the Company proposes to amend its Bylaws (the "Bylaws Amendment") in order to increase the size of the Company's Board of Directors from two (2) to a range of five (5) to nine (9), with the exact number of directors to be seven (7) (the "Bylaws Amendment").
The Board of Directors of the Company approves of implementing the Bylaws Amendment because the Board of Directors believes that increasing the size of the Company's Board of Directors is necessary to allow the Company to add additional advisors to the Board of Directors, including advisors who are independent as defined in Rule 4200 of Financial Industry Regulatory Authority's listing standards.
The Company is not expected to experience a tax consequence as a result of the Bylaws Amendment.
VOTE REQUIRED AND BOARD RECOMMENDATION
Approval of the Bylaws Amendment requires the affirmative written consent of shareholders holding at least a majority of the Company's outstanding common stock. The directors and executive officers of the Company, holding an aggregate of 97,339,955 voting shares or 39% of our common stock as of October 31, 2008, intend to vote FOR approval of the Amendment.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE COMPANY
GIVE THEIR WRITTEN CONSENT IN FAVOR OF THE BYLAWS AMENDMENT.
-4-
--------------------------------------------------------------------------------
ADDITIONAL INFORMATION
Additional information regarding the Company, its business, its capital stock, and its financial condition are included in the Company's Form 10-KSB annual report and its Form 10-Q quarterly reports. Copies of the Company's Form 10-KSB for its fiscal year ending December 31, 2007, as well as the Company's Form 10-Q for the quarters ending March 31, 2008 and June 30, 2008, are available upon request to: Dean Janes, Chief Executive Officer, Imaging3, Inc., 3200 W. Valhalla Drive, Burbank, California 91505.
OTHER MATTERS
The Board of Directors of the Company is not aware that any matter other than those described in this Schedule 14A Information Statement is to be presented for the consent of the shareholders.
UPON WRITTEN REQUEST BY ANY SHAREHOLDER TO DEAN JANES, CHIEF EXECUTIVE OFFICER OF THE COMPANY, AT IMAGING3, INC., 3200 W. VALHALLA DRIVE, BURBANK, CALIFORNIA 91505, TELEPHONE (818) 260-0930, A COPY OF THE COMPANY'S ANNUAL REPORT ON FORM 10-KSB WILL BE PROVIDED WITHOUT CHARGE.
-5-
--------------------------------------------------------------------------------
EXHIBIT A
AMENDMENT TO BYLAWS
--------------------------------------------------------------------------------
AMENDMENT TO
BYLAWS
OF
IMAGING3, INC.
A CALIFORNIA CORPORATION
The following provision of the Bylaws of Imaging3, Inc. adopted on or about December 9, 2008 (the "Bylaws") is hereby amended and restated (the "Amendment"):
Article III, Section 2 of the Company's Bylaws is hereby amended and restated in its entirety as follows: "Number. The Corporation shall have no fewer than five (5) nor more than nine (9) directors. Initially the exact number of directors will be seven (7). The exact number of directors will be determined from time to time by resolution adopted by approval of the outstanding shares or by the affirmative vote of a majority of the Whole Board of Directors. Notwithstanding the foregoing, before the issuance of any shares and so long as the Corporation has only one shareholder, the number of directors may be one or two, and so long as the Corporation has two shareholders, the number may be two. As used in these Bylaws, the term "Whole Board" means the number of directors that the Corporation would have if there were no vacancies. After the issuance of shares, a bylaw specifying the changing of the maximum or minimum number of directors or changing from a variable to a fixed board or vice versa may be adopted only by approval of the outstanding shares. No reduction of the authorized number of directors shall have the effect of removing any director before the expiration of his term of office."
The Bylaws shall remain in effect as modified by this Amendment to the Bylaws (the "Amendment") except to the extent that the Bylaws contradict the Amendment, in which case this Amendment shall govern.
THIS IS TO CERTIFY:
That I am the duly elected, qualified and acting Secretary of Imaging3, Inc., a California corporation (the "Company"), and that the foregoing Amendment to the Bylaws was validly adopted on December 9, 2008 by written consent of the shareholders entitled to vote a majority of the outstanding capital stock of the Company.
IN WITNESS WHEREOF, I have hereunto set my hand this 9th day of December 2008.
--------------------------------------------------------------------------------
Xavier Aguilera, Secretary
--------------------------------------------------------------------------------
EXHIBIT B
AMENDMENT TO ARTICLES
--------------------------------------------------------------------------------
AMENDMENT TO
ARTICLES OF INCORPORATION
OF
IMAGING3, INC.
The undersigned, Dean Janes and Xavier Aguilera, hereby certify that:
1. They are the Chief Executive Officer and Secretary, respectively, of Imaging3, Inc., a California corporation (the "Corporation").
2. The Articles of Incorporation of the Corporation are hereby amended as follows:
Article IV is hereby amended and restated to read as follows:
IV.: The Corporation is authorized to issue two classes of shares. One class of shares shall be designated as common stock, par value $0.001 per share, and the total number of common shares which this Corporation is authorized to issue is 750,000,000. The other class of shares shall be designated as preferred stock, par value $0.001 per share, and the total number of preferred shares which this Corporation is authorized to issue is 1,000,000. The preferred stock authorized by these Articles of Incorporation shall be issued in series. The Board of Directors of this Corporation is authorized to determine or alter the rights, preferences, privileges, and restrictions granted to or imposed upon any wholly unissued series of preferred stock, and within the limitations or restrictions stated in any resolution or resolutions of the Board of Directors originally fixing the number of shares constituting any series, to increase or decrease (but not below the number of shares of any such series then outstanding) the number of shares of any such series subsequent to the issue of shares of that series, to determine the designation and par value of any series, and to fix the number of shares of any series.
3. The foregoing Amendment to Articles of Incorporation has been duly approved by the Board of Directors.
4. The foregoing Amendment to the Articles of Incorporation has been duly approved by the required vote of shareholders in accordance with Section 902 of the Corporations Code. The total number of outstanding shares of the Corporation entitled to vote is 248,924,052 shares of Common Stock. The number of shares voting in favor of the amendment equaled or exceeded the vote required. The percentage vote required was more than fifty percent (50%).
The undersigned further declare under penalty of perjury under the laws of the State of California that the matters set forth in this certificate are true and correct of their own knowledge.
Dated: December 9, 2008
--------------------------------------------------------------------------------
Dean Janes, Chief Executive Officer
--------------------------------------------------------------------------------
Xavier Aguilera, Secretary
--------------------------------------------------------------------------------
WRITTEN CONSENT OF SHAREHOLDERS OF IMAGING3, INC.
APPROVING AMENDMENT TO THE COMPANY'S ARTICLES OF INCORPORATION AND
AMENDMENT TO THE COMPANY'S BYLAWS
The undersigned shareholder(s) of Imaging 3, Inc. (the "Company") hereby:
|_| CONSENTS TO |_| DOES NOT CONSENT TO |_| ABSTAINS WITH RESPECT TO
a proposal to amend ARTICLE IV of the Company's Articles of Incorporation to effect such action (the "Articles Amendment") as described in the accompanying Consent Solicitation Statement of the Company dated November 5, 2008.
|_| CONSENTS TO |_| DOES NOT CONSENT TO |_| ABSTAINS WITH RESPECT TO
a proposal to amend Article III, Section 2 of the Company's Bylaws to effect such action (the "Bylaws Amendment") as described in the accompanying Consent Solicitation Statement of the Company dated November 5, 2008.
By signing this written consent, a shareholder of the Company shall be deemed to have voted all shares of the Company's common stock which he or she is entitled to vote in accordance with the specifications made above, with respect to the Articles Amendment and Bylaws Amendment described above. IF A SHAREHOLDER SIGNS AND RETURNS THIS WRITTEN CONSENT, BUT DOES NOT INDICATE THEREON THE MANNER IN WHICH HE OR SHE WISHES HIS OR HER SHARES TO BE VOTED WITH RESPECT TO THE PROPOSAL DESCRIBED ABOVE, THEN SUCH SHAREHOLDER WILL BE DEEMED TO HAVE GIVEN HIS OR HER AFFIRMATIVE WRITTEN CONSENT IN FAVOR OF APPROVAL OF THE ARTICLE AMENDMENT AND BYLAWS AMENDMENT.
THIS WRITTEN CONSENT IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF THE COMPANY. THIS WRITTEN CONSENT MAY BE REVOKED AT ANY TIME PRIOR TO DECEMBER 8, 2008 BY FILING A WRITTEN INSTRUMENT REVOKING THE CONSENT WITH THE COMPANY'S SECRETARY.
THE COMPANY'S BOARD OF DIRECTORS RECOMMENDS THAT YOU GIVE YOUR AFFIRMATIVE WRITTEN CONSENT IN FAVOR OF APPROVAL OF THE ARTICLES AMENDMENT AND BYLAWS AMEMDMENT.
--------------------------------------------------------------------------------
(Number of Shares)
Date:__________________________
--------------------------------------------------------------------------------
(Please Print Name)
--------------------------------------------------------------------------------
(Signature of Shareholder)
--------------------------------------------------------------------------------
(Please Print Name)
--------------------------------------------------------------------------------
(Signature of Shareholder)
(Please date this written
consent and sign your name as
it appears on your stock
certificate. Executors,
administrators, trustees,
etc., should give their full
titles. All joint owners
should sign.)
PLEASE COMPLETE AND RETURN TO THE COMPANY
BY DECEMBER 9, 2008.
So Friday was the last day
if they don't have news by Monday AM it's overf
JMHO
Be patient, as I've stated it really isn't a question of whether we will recieve approval but when...
Dean
February 21, 2008
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=27004301
The guys that bought the stock at 2c are hedging and will borrow all they can as they know that by the time the 120 million shares will hit the market it will trade at pennies
FDA will NEVER happen
All u get is CC's and money TV shows
Can someone explain why in the last Q they say CEO paid back the $ but on balance sheet they have it as Other receivables-related party 1,088,934 ??
what part of the Q is true or fallse?
Filing Date: 11/13/2009 Form Type: 10-Q
11. OTHER RECEIVABLES - RELATED PARTY
During the quarter ended September 30, 2009, the Company remitted $1,088,934 to its Chief Executive Officer as over funding of previous borrowings made by the Company from him. The amount remitted was inadvertently calculated to be in excess of the amount actually owed by the Company to its CEO. Accordingly, upon realizing the miscalculations, the Company CEO immediately transferred the net receivable balance back to the Company subsequent to September 30, 2009.
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
-1-
--------------------------------------------------------------------------------
IMAGING3, INC.
BALANCE SHEETS
AT SEPTEMBER 30, 2009 (UNAUDITED) AND DECEMBER 31, 2008
ASSETS
9/30/2009 12/31/2008
---------------- ---------------
(UNAUDITED)
CURRENT ASSETS:
Cash and cash equivalents $ 154,412 $ 73,447
Accounts receivable, net 55,267 64,149
Other receivables-related party 1,088,934 -
Inventory, net 332,014 328,740
Prepaid expenses 31,240 21,148
---------------- ---------------
Total current assets 1,661,867 487,484
PROPERTY AND EQUIPMENT, NET 17,244 23,755
OTHER ASSETS 31,024 31,024
---------------- ---------------
Total assets $ 1,710,135 $ 542,263
================ ===============
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable $ 131,140 $ 175,329
Accrued expenses 2,307,091 2,270,638
Deferred revenue 195,846 119,052
Equipment deposits 223,360 116,368
Due to an officer - 784,210
---------------- ---------------
Total current liabilities 2,857,437 3,465,597
STOCKHOLDERS' DEFICIT:
Common stock, no par value; authorized shares 500,000,000;
375,709,898 and 249,924,052 issued and outstanding
at September 30, 2009 and December 31, 2008, respectively 10,988,572 7,763,772
Accumulated deficit (12,135,874) (10,687,106)
---------------- ---------------
Total stockholders' deficit (1,147,302) (2,923,334)
---------------- ---------------
Total liabilities and stockholders' deficit $ 1,710,135 $ 542,263
================ ===============
The accompanying notes form an integral part of these unaudited financial statements
-2-
but after selling 120m stock at 2.5c a share they still have only 150k in the bank
COMMON STOCK
During the nine month period ended September 30, 2009, the Company issued 119,934,027 shares of common stock for cash proceeds of $3,083,854 net of offering costs of $113,622 as part of its private placement.
During the nine month period ended September 30, 2009, the Company issued 5,164,319 shares of common stock for the conversation of $100,000 in debt owed. Per the terms of the conversion feature of the note, the principal balance was convertible into 5,000,000 shares. The excess of the shares issued was recorded as a loss on conversion of debt of $6,571.
During the nine month period ended September 30, 2009, the Company issued 687,500 shares of common stock for services rendered for a total of $34,375.
ASSETS
9/30/2009 12/31/2008
---------------- ---------------
(UNAUDITED)
CURRENT ASSETS:
Cash and cash equivalents $ 154,412 $ 73,447
Accounts receivable, net 55,267 64,149
Other receivables-related party 1,088,934 -
Inventory, net 332,014 328,740
Prepaid expenses 31,240 21,148
---------------- ---------------
Just look at SEC filing
they have 150k
Link To This Article:
- Quarterly Report (10-Q)
Date : 11/13/2009 @ 3:00PM
Source : Edgar (US Regulatory)
Stock : (IMGG)
Quote : 1.19 -0.03 (-2.46%) @ 8:19AM
- Quarterly Report (10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For Quarterly Period Ended September 30, 2009
or
[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the Transition period from _______________ to ______________
Commission File Number: 000-50099
--------------------------------------------------------------------------------
IMAGING3, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
CALIFORNIA 95-4451059
------------------------------------ --------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
3200 WEST VALHALLA DRIVE, BURBANK, CALIFORNIA 91505
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(818) 260-0930
--------------------------------------------------------------------------------
Registrant's telephone number, including area code
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the proceeding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes[__] No[_X_]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check One).
Large accelerated filer [___] Accelerated filer [___]
Non-accelerated filer [___] Smaller reporting company [_X_]
(Do not check if a smaller
reporting company)
Indicate by check mark whether the Registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
Yes[__] No[_X_]
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.
As of November 1, 2009, the number of shares outstanding of the registrant's class of common stock was 375,709,898.
--------------------------------------------------------------------------------
TABLE OF CONTENTS
PAGE
PART I. FINANCIAL INFORMATION...........................................................................1
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)................................................................1
BALANCE SHEETS AT SEPTEMBER 30, 2009 (UNAUDITED) AND DECEMBER 31, 2008..........................2
STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2009 AND
SEPTEMBER 30, 2008 (UNAUDITED)..................................................................3
STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009 AND SEPTEMBER
30, 2008 (UNAUDITED)............................................................................4
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS..........12
ITEM 4. CONTROLS AND PROCEDURES........................................................................16
PART II. OTHER INFORMATION.......................................................................................18
ITEM 1. LEGAL PROCEEDINGS..............................................................................18
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS....................................18
ITEM 3. DEFAULTS UPON SENIOR SECURITIES................................................................18
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS...........................................18
ITEM 5. OTHER INFORMATION..............................................................................18
ITEM 6. EXHIBITS.......................................................................................19
SIGNATURES.......................................................................................................20
--------------------------------------------------------------------------------
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
-1-
--------------------------------------------------------------------------------
IMAGING3, INC.
BALANCE SHEETS
AT SEPTEMBER 30, 2009 (UNAUDITED) AND DECEMBER 31, 2008
ASSETS
9/30/2009 12/31/2008
---------------- ---------------
(UNAUDITED)
CURRENT ASSETS:
Cash and cash equivalents $ 154,412 $ 73,447
Accounts receivable, net 55,267 64,149
Other receivables-related party 1,088,934 -
Inventory, net 332,014 328,740
Prepaid expenses 31,240 21,148
---------------- ---------------
Total current assets 1,661,867 487,484
PROPERTY AND EQUIPMENT, NET 17,244 23,755
OTHER ASSETS 31,024 31,024
---------------- ---------------
Total assets $ 1,710,135 $ 542,263
================ ===============
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable $ 131,140 $ 175,329
Accrued expenses 2,307,091 2,270,638
Deferred revenue 195,846 119,052
Equipment deposits 223,360 116,368
Due to an officer - 784,210
---------------- ---------------
Total current liabilities 2,857,437 3,465,597
STOCKHOLDERS' DEFICIT:
Common stock, no par value; authorized shares 500,000,000;
375,709,898 and 249,924,052 issued and outstanding
at September 30, 2009 and December 31, 2008, respectively 10,988,572 7,763,772
Accumulated deficit (12,135,874) (10,687,106)
---------------- ---------------
Total stockholders' deficit (1,147,302) (2,923,334)
---------------- ---------------
Total liabilities and stockholders' deficit $ 1,710,135 $ 542,263
================ ===============
The accompanying notes form an integral part of these unaudited financial statements
-2-
--------------------------------------------------------------------------------
IMAGING3, INC.
STATEMENTS OF OPERATIONS
(UNAUDITED)
For the three month periods For the nine month periods
ended September 30, ended September 30,
2009 2008 2009 2008
-------------- --------------- --------------- ----------------
NET REVENUES $ 224,747 $ 505,361 $ 799,243 $ 1,407,424
COST OF GOODS SOLD 80,115 264,101 337,483 558,327
-------------- --------------- --------------- ----------------
GROSS PROFIT 144,632 241,260 461,760 849,097
OPERATING EXPENSES:
General and administrative expenses 509,226 505,431 1,629,546 1,644,838
-------------- --------------- --------------- ----------------
Total operating expenses 509,226 505,431 1,629,546 1,644,838
-------------- --------------- --------------- ----------------
LOSS FROM OPERATIONS (364,594) (264,171) (1,167,786) (795,741)
OTHER INCOME (EXPENSE):
Interest expense (11,746) 631 (41,021) (36,038)
Gain on litigation settlement 39,000 155,000 39,000 156,977
Other expense (282,871) - (282,871) -
Other income 4,682 170,372 4,710 170,372
-------------- --------------- --------------- ----------------
Total other income (expense) (250,935) 326,003 (280,182) 291,311
-------------- --------------- --------------- ----------------
INCOME (LOSS) BEFORE INCOME TAX (615,529) 61,832 (1,447,968) (504,430)
PROVISION FOR INCOME TAXES - - 800 800
-------------- --------------- --------------- ----------------
NET INCOME (LOSS) $ (615,529) $ 61,832 $ (1,448,768) $ (505,230)
============== =============== =============== ================
BASIC AND DILUTED NET LOSS PER SHARE $ (0.00) $ 0.00 $ (0.01) $ (0.00)
============== =============== =============== ================
WEIGHTED AVERAGE COMMON STOCK OUTSTANDING 285,397,317 248,452,240 267,148,101 240,389,513
============== =============== =============== ================
The accompanying notes form an integral part of these unaudited financial statements
-3-
--------------------------------------------------------------------------------
IMAGING3, INC.
STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 2009 AND SEPTEMBER 30, 2008 (UNAUDITED)
2009 2008
---------------- ----------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (1,448,768) $ (505,230)
Adjustments to reconcile net loss to net cash used for
operating activities:
Depreciation and amortization 6,511 12,953
Common stock issued for services and R&D 34,375 73,133
Gain on settlement of debt (39,000) (156,977)
Loss on conversion of debt 6,571 -
(Increase) / decrease in current assets:
Accounts receivable 8,882 (53,151)
Inventory (3,274) (159,434)
Prepaid expenses and other assets (10,092) (28,255)
Increase / (decrease) in current liabilities:
Accounts payable (44,191) (97,180)
Accrued expenses 75,455 (307,381)
Deferred revenue 76,794 (4,250)
Equipment deposits 106,992 (85,404)
---------------- ----------------
Net cash used for operating activities (1,229,745) (1,311,176)
---------------- ----------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant, and equipment - (22,992)
---------------- ----------------
Net cash used for investing activities - (22,992)
---------------- ----------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Receipts from / (payments to) officer, net (1,773,144) 74,666
Proceeds from issuance of common stock, net 3,083,854 1,259,072
---------------- ----------------
Net cash provided by financing activities 1,310,710 1,333,738
---------------- ----------------
NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS 80,965 (429)
CASH & CASH EQUIVALENTS, BEGINNING BALANCE 73,447 2,293
---------------- ----------------
CASH & CASH EQUIVALENTS, ENDING BALANCE $ 154,412 $ 1,864
================ ================
The accompanying notes form an integral part of these unaudited financial statements
-4-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
1. ORGANIZATION AND DESCRIPTION OF BUSINESS
Imaging3, Inc. (the "Company") is a California corporation incorporated on October 29, 1993, as Imaging Services, Inc. The Company filed a certificate of amendment of articles of incorporation to change its name to Imaging3, Inc. on August 20, 2002.
The Company's primary business is production and sale of medical equipment, parts and services to hospitals, surgery centers, research labs, physician offices and veterinarians. Equipment sales include new c-arms, c-arm tables, remanufactured c-arms, and used c-arm and surgical tables. Part sales consist of new or renewed replacement parts for c-arms.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
A summary of the Company's significant accounting policies consistently applied in the preparation of the accompanying financial statements follows:
The accompanying unaudited interim financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission for the presentation of interim financial information, but do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2008. The Company follows the same accounting policies in preparation of interim reports. Results of operations for the interim periods are not indicative of annual results.
USE OF ESTIMATES
In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.
DUE TO OFFICER
At September 30, 2009 and December 31, 2008, the Company had a balance due to the Chief Executive Officer of the Company amounting to $-0- and $784,210, respectively, for amounts borrowed by the company. Final payment was effected during the third quarter of 2009.
EQUIPMENT DEPOSITS
Equipment deposits represent amounts received from customers against future sales of goods since the Company recognizes revenue upon shipment of goods. These deposits are applied to the invoices when the equipment is shipped to the customers. The balance at September 30, 2009 and December 31, 2008, was $223,360 and $116,368, respectively.
-5-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
REVENUE RECOGNITION
Revenue is recognized upon shipment, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable and collection of the related receivable is reasonably assured. Revenue is recorded net of estimated product returns, which is based upon the Company's return policy, sales agreements, management estimates of potential future product returns related to current period revenue, current economic trends, changes in customer composition and historical experience. The Company accrues for warranty costs, sales returns, and other allowances based on its experience. Generally, the Company extends credit to its customers and does not require collateral. The Company performs ongoing credit evaluations of its customers and historic credit losses have been within management's expectations. The Company sells warranties and recognizes warranty revenue over the term of the warranty period. Deferred revenue is recognized at the time of warranty sales.
INCOME TAXES
Deferred income taxes are reported using the liability method. Deferred tax assets are recognized for deductible temporary differences and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
BASIC AND DILUTED NET LOSS PER SHARE
Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all dilutive convertible shares and stock options were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. No adjustment has been made for any common stock equivalents outstanding because their effects would be anti-dilutive.
SUBSEQUENT EVENTS
The management of the Company has evaluated the period after the balance sheet date up through October 26, 2009, which is the date that the financial statements were issued, and determined that there were no subsequent events or transactions that required recognition or disclosure in the financial statements.
NEW ACCOUNTING STANDARDS
On January 1, 2009, the Company adopted a new accounting standard issued by the FASB related to accounting for business combinations using the acquisition method of accounting (previously referred to as the purchase method). Among the significant changes, this standard requires a redefining of the measurement date of a business combination, expensing direct transaction costs as incurred, capitalizing in-process research and development costs as an intangible asset and recording a liability for contingent consideration at the measurement date with subsequent re-measurements recorded in the results of operations. This standard also requires costs for business restructuring and exit activities related to the acquired company to be included in the
-6-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
post-combination financial results of operations and also provides new guidance for the recognition and measurement of contingent assets and liabilities in a business combination. In addition, this standard requires several new disclosures, including the reasons for the business combination, the factors that contribute to the recognition of goodwill, the amount of acquisition related third-party expenses incurred, the nature and amount of contingent consideration, and a discussion of pre-existing relationships between the parties.
The application of this standard is likely to have a significant impact on how the Company allocates the purchase price of prospective business combinations, including the recognition and measurement of assets acquired and liabilities assumed and the expensing of direct transaction costs and costs to integrate the acquired business.
On January 1, 2009, the Company adopted a new accounting standard issued by the FASB that establishes accounting and reporting standards for noncontrolling interests in a subsidiary in consolidated financial statements, including deconsolidation of a subsidiary. This standard requires entities to record the acquisition of noncontrolling interests in subsidiaries initially at fair value. The adoption of this standard did not impact earnings per share attributable to Imaging3, Inc.'s common stockholders. There were no changes in the Company's ownership interests for the three or nine months ended September 30, 2009.
On January 1, 2009, the Company adopted a new accounting standard issued by the FASB related to the disclosure of derivative instruments and hedging activities. This standard expanded the disclosure requirements about an entity's derivative financial instruments and hedging activities, including qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.
Effective June 30, 2009, the Company adopted a new accounting standard issued by the FASB related to the disclosure requirements of the fair value of financial instruments. This standard expands the disclosure requirements of fair value (including the methods and significant assumptions used to estimate fair value) of certain financial instruments to interim period financial statements that were previously only required to be disclosed in financial statements for annual periods. In accordance with this standard, the disclosure requirements have been applied on a prospective basis and did not have a material impact on the Company's financial statements.
Effective June 30, 2009, the Company adopted a newly issued accounting standard related to accounting for and disclosure of subsequent events in its financial statements. This standard provides the authoritative guidance for subsequent events that was previously addressed only in United States auditing standards. This standard establishes general accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued and requires the Company to disclose the date through which it has evaluated subsequent events and whether that was the date the financial statements were issued or available to be issued. This standard does not apply to subsequent events or transactions that were within the scope of other applicable GAAP that provide different guidance on the accounting treatment for subsequent events or transactions. The adoption of this standard did not have a material impact on the Company's financial statements.
In June 2009, the FASB issued an amendment to the accounting standards related to the consolidation of variable interest entities ("VIE"). This standard provides a new approach for determining which entity should consolidate a VIE, how and when to reconsider the consolidation or deconsolidation of a VIE and requires disclosures about an entity's significant judgments and assumptions used in its decision to consolidate or not consolidate a VIE. Under this
-7-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
standard, the new consolidation model is a more qualitative assessment of power and economics that considers which entity has the power to direct the activities that "most significantly impact" the VIE's economic performance and has the obligation to absorb losses or the right to receive benefits that could be potentially significant to the VIE. This standard is effective for the Company as of January 1, 2010 and the Company does not expect the impact of its adoption to be material to its financial statements.
In August 2009, the FASB issued an amendment to the accounting standards related to the measurement of liabilities that are recognized or disclosed at fair value on a recurring basis. This standard clarifies how a company should measure the fair value of liabilities and provides that restrictions preventing the transfer of a liability should not be considered as a factor in the measurement of liabilities within the scope of this standard. This standard is effective for the Company on October 1, 2009. The Company does not expect the impact of its adoption to be material to its financial statements.
In October 2009, the FASB issued an amendment to the accounting standards related to the accounting for revenue in arrangements with multiple deliverables including how the arrangement consideration is allocated among delivered and undelivered items of the arrangement. Among the amendments, this standard eliminates the use of the residual method for allocating arrangement consideration and requires an entity to allocate the overall consideration to each deliverable based on an estimated selling price of each individual deliverable in the arrangement in the absence of having vendor-specific objective evidence or other third party evidence of fair value of the undelivered items. This standard also provides further guidance on how to determine a separate unit of accounting in a multiple-deliverable revenue arrangement and expands the disclosure requirements about the judgments made in applying the estimated selling price method and how those judgments affect the timing or amount of revenue recognition. This standard, for which the Company is currently assessing the impact, will become effective for the Company on January 1, 2011.
In October 2009, the FASB issued an amendment to the accounting standards related to certain revenue arrangements that include software elements. This standard clarifies the existing accounting guidance such that tangible products that contain both software and non-software components that function together to deliver the product's essential functionality, shall be excluded from the scope of the software revenue recognition accounting standards. Accordingly, sales of these products may fall within the scope of other revenue recognition accounting standards or may now be within the scope of this standard and may require an allocation of the arrangement consideration for each element of the arrangement. This standard, for which the Company is currently assessing the impact, will become effective for the Company on January 1, 2011.
3. ACCOUNTS RECEIVABLE
All accounts receivable are trade related. These receivables are current and management believes are collectible except for those for which a reserve has been provided. The balance of accounts receivable as of September 30, 2009 was $55,267 as compared to $64,149 as of December 31, 2008. The reserve amount for uncollectible accounts was $1,375 as of both September 30, 2009 and December 31, 2008.
-8-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
4. INVENTORIES
Inventory consisted of the following:
09/30/09 12/31/08
------------ -------------
Parts inventory $ 214,747 $ 137,048
Finished goods 347,239 421,664
Inventory reserve (229,972) (229,972)
------------ -------------
Total, net $ 332,014 $ 328,740
============ =============
5. PROPERTIES AND EQUIPMENT
Property and equipment consisted of the following:
09/30/09 12/31/08
-------------- -------------
Furniture and office equipment $ 78,694 $ 78,694
Tools and shop equipment 54,183 54,183
Vehicles 105,871 105,871
-------------- -------------
238,748 238,748
Less Accumulated depreciation (221,504) (214,993)
-------------- -------------
Total, net $ 17,244 $ 23,755
============== =============
Depreciation expenses were $6,511 and $12,953 for the nine months ended September 30, 2009 and 2008, respectively.
6. ACCRUED EXPENSES
Accrued expenses consisted of the following:
09/30/09 12/31/08
-------------- -------------
Accrued payroll taxes $ 163,540 $ 30,352
Other accrued expenses 26,485 16,501
Accrued legal fees 436,015 416,620
Accrued ongoing litigation 1,681,051 1,807,165
-------------- -------------
Total $2,307,091 $2,270,638
============== =============
During 2003, the Company paid payroll net of taxes and accrued said taxes without payment due to cash flow limitations resulting from a 2002 warehouse fire that incinerated our inventory. The Company subsequently received a tax lien in 2005 related to 2003 payroll taxes from the Internal Revenue Service and continued to accrue interest and penalty charges. The original amount was $104,000. In 2008, payments were made and the Internal Revenue Service issued a tax lien release for this amount and the liability carried on the Company's books was relieved. In 2009, the Company was notified by the Internal Revenue Service that additional payroll taxes, interest, and penalty charges were still owed. After researching, it is believed that the Internal Revenue Service double booked the original payments made and released the lien in error. Settlement was reached and the Company is currently paying $2,000 per month with a potential balloon payment in one year subject to re-negotiation after one year with the IRS. During this period, the Company also entered into
-9-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
an arrangement to pay one of its litigated settlements of $78,000 for $39,000, thereby allowing a gain of $39,000 on this transaction.
7. STOCKHOLDERS' EQUITY
COMMON STOCK
During the nine month period ended September 30, 2009, the Company issued 119,934,027 shares of common stock for cash proceeds of $3,083,854 net of offering costs of $113,622 as part of its private placement.
During the nine month period ended September 30, 2009, the Company issued 5,164,319 shares of common stock for the conversation of $100,000 in debt owed. Per the terms of the conversion feature of the note, the principal balance was convertible into 5,000,000 shares. The excess of the shares issued was recorded as a loss on conversion of debt of $6,571.
During the nine month period ended September 30, 2009, the Company issued 687,500 shares of common stock for services rendered for a total of $34,375.
8. SUPPLEMENTAL DISCLOSURE OF CASH FLOWS
The Company paid income taxes of $800 and interest of $7,573 during the nine month period ended September 30, 2009. The Company paid income taxes of $800 and interest of $9,883 during the nine month period ended September 30, 2008.
9. GOING CONCERN
The Company's nine month financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. In the three month periods ended September 30, 2009 and 2008, the Company incurred losses of $615,529 and revenue of $61,832, respectively. Revenue in the third quarter of 2008 occurred as a result of strong sales. The Company has an accumulated deficit of $12,135,874 as of September 30, 2009. The continuing losses have adversely affected the liquidity of the Company.
In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheets is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to raise additional capital, obtain financing and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
Management has taken the following steps to revise its operating and financial requirements, which it believes are sufficient to provide the Company with the ability to continue as a going concern. Management devoted considerable effort during the nine month period ended September 30, 2009, towards (i) obtaining additional equity capital, and in that regard, in 2009 the Company was in the process of offering to sell shares at $0.025 per share in a private placement to accredited investors, (ii) controlling of salaries and general and administrative expenses, (iii) management of accounts payable, (iv) evaluation of its distribution and marketing methods, and (v) increasing marketing and sales. In order to control general and administrative expenses, the Company has established internal financial controls in all areas, specifically in hiring and
-10-
--------------------------------------------------------------------------------
IMAGING3, INC.
NOTES TO FINANCIAL STATEMENTS - UNAUDITED
overhead cost. The Company has also established a hiring policy under which the Company will refrain from hiring additional employees unless approved by the CEO and CFO. Accounts payable are reviewed and approved or challenged on a daily basis and the sales staff is questioned as to the validity of any expense on a monthly basis. Senior management reviews the annual budget to ascertain and question any variance from plan, on a quarterly basis, and to anticipate and make adjustments as may be feasible.
10. RELATED PARTY TRANSACTION
The Company has a consulting agreement with the Chief Executive Officer of the Company for compensation of $12,000 per month. The CEO provides services to the Company for management, administrative, marketing, and financial matters pursuant to the consulting agreement terminable on 30 days notice by either party. The consulting agreement commenced on January 1, 2002, and will continue until such time as the Company withdraws the agreement or the CEO resigns. The accrued compensation has been included in amounts due to officer and is payable by the Company on demand.
During the normal course of business, the Chief Executive Officer advances funds to the Company and in turn the Company will reimburse him. These transactions are recorded as due to officer.
The balance of due to officer amounts to $-0- as of September 30, 2009 and $784,210 as of December 31, 2008.
During the nine months ended September 30, 2009, the Chief Executive Officer was paid $1,773,144 of the amount that was owed to him. This amount included adjustments for funds not recorded in 2004 and 2005.
11. OTHER RECEIVABLES - RELATED PARTY
During the quarter ended September 30, 2009, the Company remitted $1,088,934 to its Chief Executive Officer as over funding of previous borrowings made by the Company from him. The amount remitted was inadvertently calculated to be in excess of the amount actually owed by the Company to its CEO. Accordingly, upon realizing the miscalculations, the Company CEO immediately transferred the net receivable balance back to the Company subsequent to September 30, 2009.
12. SUBSEQUENT EVENTS
Subsequent to September 30, 2009, the Company's CEO transferred the net receivable balance recorded as "Other receivables-related party" back to the Company.
There are no additional significant subsequent events to report through November 12, 2009, the date the financial statements were issued.
-11-
--------------------------------------------------------------------------------
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY STATEMENTS
This Form 10-Q may contain "forward-looking statements," as that term is used in federal securities laws, about Imaging3, Inc.'s financial condition, results of operations and business. These statements include, among others:
o statements concerning the potential benefits that Imaging3, Inc. ("Imaging3" or the "Company") may experience from its business activities and certain transactions it contemplates or has completed; and
o statements of Imaging3's expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this Form 10-Q. You can find many of these statements by looking for words such as "believes," "expects," "anticipates," "estimates," "opines," or similar expressions used in this Form 10-Q. These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause Imaging3's actual results to be materially different from any future results expressed or implied by Imaging3 in those statements. The most important facts that could prevent Imaging3 from achieving its stated goals include, but are not limited to, the following:
(a) volatility or decline of Imaging3's stock price;
(b) potential fluctuation in quarterly results;
(c) failure of Imaging3 to earn revenues or profits;
(d) inadequate capital to continue or expand its business, and inability to raise additional capital or financing to implement its business plans;
(e) failure to commercialize Imaging3's technology or to make sales;
(f) reductions in demand for Imaging3's products and services;
(g) rapid and significant changes in markets;
(h) litigation with or legal claims and allegations by outside parties;
(i) insufficient revenues to cover operating costs;
(j) failure of Imaging3 to obtain approval of its proprietary medical imaging technology and device from the United States Food and Drug Administration.
There is no assurance that Imaging3 will be profitable; Imaging3 may not be able to successfully develop, manage or market its products and services; Imaging3 may not be able to attract or retain qualified executives and technology personnel; Imaging3 may not be able to obtain customers for its products or services; Imaging3's products and services may become obsolete; government regulation may hinder Imaging3's business; Imaging3 may not be able to obtain the required approvals from the United States Food and Drug
-12-
--------------------------------------------------------------------------------
Administration for its products and services; additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants and stock options, or the exercise of outstanding warrants and stock options, and other risks inherent in Imaging3's businesses.
Because the statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. Imaging3 cautions you not to place undue reliance on the statements, which speak only as of the date of this Form 10-Q. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that Imaging3 or persons acting on its behalf may issue. Imaging3 does not undertake any obligation to review or confirm analysts' expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this Form 10-Q, or to reflect the occurrence of unanticipated events.
CURRENT OVERVIEW
Though our efforts have been to market our refurbished equipment, the sales and revenues from service and parts are increasing, either from extended warranty purchases at the time of purchase of the refurbished equipment, or service contracts and time and material revenue realized upon warranty expiration, the majority of which is realized one year from equipment purchase as warranties expire.
Our sales efforts through direct mail, broadcast facsimile and broadcast email to thousands of potential customers throughout the United States generates leads of potential customers desiring to purchase equipment either immediately or in the course of one year. This lead generation through direct mail, broadcast facsimile and email will continue on a quarterly basis with the goal of increasing the total number of leads for our sales staff. Management expects that the marketing program will also eventually help stabilize the amount of refurbished equipment sold on a monthly basis, since the carry-over of leads not looking for immediate purchase will overlap with the immediate sales leads. The greater the number of leads generated, whether immediate or long term, the greater the opportunity to eventually create a consistent number of sales.
CRITICAL ACCOUNTING POLICIES
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We monitor our estimates on an on-going basis for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. We base our estimates on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.
We have identified the policies below as critical to our business operations and the understanding of our results of operations.
REVENUE RECOGNITION. We recognize revenue upon shipment, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. We record revenue net of estimated product returns, which is based upon our return policy, sales agreements, management estimates of potential future product returns related to current period revenue,
-13-
--------------------------------------------------------------------------------
current economic trends, changes in customer composition and historical experience. We accrue for warranty costs, sales returns, and other allowances based on our experience. Generally, we extend credit to our customers and do not require collateral. We perform ongoing credit evaluations of our customers and historic credit losses have been within our expectations. We do not ship a product until we have either a purchase agreement or rental agreement signed by the customer with a payment arrangement. This is a critical policy, because we want our accounting to show only sales which are "final" with a payment arrangement. We do not make consignment sales, nor inventory sales subject to a "buy back" or return arrangement from customers.
PROVISION FOR SALES RETURNS, ALLOWANCES AND BAD DEBTS. The Company maintains a provision for sales allowances, returns and bad debts. Sales returns and allowances result from equipment damaged in delivery or customer dissatisfaction, as provided by agreement. The provision is provided for by reducing gross revenue by a portion of the amount invoiced during the relevant period. The amount of the reduction is estimated based on historical experience.
RESERVE FOR OBSOLETE/EXCESS INVENTORY. Inventories are stated at the lower of cost or market. We regularly review our inventories and, when required, will record a provision for excess and obsolete inventory based on factors that may impact the realizable value of our inventory including, but not limited to, technological changes, market demand, regulatory requirements and significant changes in our cost structure. If ultimate usage varies significantly from expected usage, or other factors arise that are significantly different than those anticipated by management, inventory write-downs or increases in reserves may be required.
A fire in 2002 incinerated our inventory, so we have not had to deal with significant amounts of obsolete inventory since that time. Our procedure is now to maintain only limited inventory, based on our experience in service and repair, necessary for current service and repair contracts or orders anticipated within the following 60 days. We have supply relationships with long term suppliers to provide additional parts on an as needed, prompt basis for the vast majority of repair and service parts, so obsolescence is no longer a factor in our business. We have not recorded any material amounts as charges to obsolescence since the fire in 2002 destroyed our warehouse.
RENTAL INCOME Rental income is recognized when earned and expenses are recognized when incurred. The rental periods vary based on customer's needs ranging from 5 days to 6 months. An operating lease agreement is utilized. The rental revenues were insignificant in the three and nine month periods ended September 30, 2009 and 2008. Written rental agreements are used in all instances.
OTHER ACCOUNTING FACTORS
The effects of inflation have not had a material impact on our operation, nor are they expected to in the immediate future.
Although we are unaware of any major seasonal aspect that would have a material effect on the financial condition or results of operation, the first quarter of each fiscal year is always a financial concern due to slow collections after the holidays.
The deposits that are shown in the financials are for pending sales of existing products and not any new patented product. These are deposits received from our customers for sales of equipment and services and are only removed as deposits upon completion of the sale. If for whatever reason a customer order is cancelled the deposit would be returned as stated in the terms of sale, minus a restocking fee.
-14-
--------------------------------------------------------------------------------
No depositor is a related party of any officer or employee of Imaging3, Inc.
Our terms of deposit typically are 50% down with the balance of the sale price due upon delivery.
RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2009 COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2008
We had revenues in the first nine months of 2009 of $799,243 compared to $1,407,424 for the same period in 2008, which represents a 56% decrease. The decrease in revenue is due in part to the Company's focus on obtaining approval for its new proprietary medical device but the Company intends to refocus on the marketing, sale and provision of its historic products and services as well. Our equipment sales were $375,264 in the first nine months of 2009, compared to $1,058,768 during the same period in 2008, representing a decrease in equipment sales of $1,023,504 in 2009. Our service and parts sales for the first nine months of 2009 were $250,750 compared to $211,407 during the same period in 2008. The Company will continue to focus on increasing its revenue in this area as well.
Our cost of revenue was $337,483 in the first nine months of 2009 compared to $558,327 in the first nine months of 2008, which represents a decrease of $220,844 or 39%. This is due in large part to the larger sales revenue in 2008. We had a decrease in gross profit margin in 2009 of $461,760 versus $849,097 in the first nine months of 2008, again due to decreased sales in 2009. Our operating expenses decreased slightly from $1,644,838 in the first nine months of 2008 to $1,629,546 in the first nine months of 2009, a 1% decrease. Our loss on operations increased to $1,167,786 in the first nine months of 2009 compared to $795,741 in the first nine months of 2008, a 68% increase. This increase is attributed to the overall decrease in revenue for this same period. Our net loss was $1,448,768 in the first nine months of 2009 compared to $505,230 in the first nine months of 2008, a 34% increase, again as a result of a decreased revenue and the recognition of a payroll tax liability with the Internal Revenue Service for $169,540 for the year ended 2003. The Company felt that this issue was resolved in an earlier period and is now settled.
RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2009 COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2008
We had revenues in the three months ended September 30, 2009 of $224,747 compared to $505,361 for the same period in 2008, which represents a 44% decrease. The decrease in revenue is due in part to the Company's focus on obtaining approval for its new proprietary medical device but the Company intends to refocus on the marketing, sale and provision of its historic products and services as well. Our equipment sales were $85,284 in the three months ended September 30, 2009, compared to $393,150 in 2008, representing a decrease in equipment sales of $307,866 in 2009 . Our service and parts sales for the three months ended September 30, 2009 were $33,665 compared to $47,962 in 2008. The Company will continue to focus on increasing its revenue in this area as well.
Our cost of revenue was $80,115 in the three months ended September 30, 2009 compared to $264,101 in the three months ended September 30, 2008, which represents a decrease of $183,986. This is due in large part to the decrease in revenue. We had a decrease in gross profit margin in the three months ended September 30, 2009 of $144,632 versus $241,260 for the same period of 2008, again due to decreased revenues. Our operating expenses increased from $505,431 in the three months ending September 30, 2008 to $509,226 for the same period in 2009, a 1% increase. Our loss on operations increased to $364,594 in the three months ended September 30, 2009 compared to $264,171 for the same period in 2008, a 38% increase. This increase is attributed to the overall decrease in revenue for this same period. Our net loss was $615,529 in the three months ending September 30, 2009 compared to a profit of $61,832 for the same period in 2008, again as a result of a decreased revenue.
-15-
--------------------------------------------------------------------------------
LIQUIDITY AND CAPITAL RESOURCES
The Company's cash position was $154,412 at September 30, 2009, compared to $73,447 at December 31, 2008.
As of September 30, 2009, the Company has current assets of $1,661,867, non-current assets of $48,268, and current liabilities of $2,857,437.
Net cash used for operating activities amounted to $1,229,745 for the nine month period ended September 30, 2009, as compared to $1,311,177 for the nine month period ended September 30, 2008. The decrease in 2009 as compared to 2008 resulted from increased net loss.
Net cash provided by financing activities amounted to $1,333,738 and $1,310,710 for the nine month periods ended September 30, 2008 and 2009, respectively. The decrease in 2009 as compared to 2008 resulted from the retirement of debt owed during the nine month period ended September 30, 2009.
GOING CONCERN QUALIFICATION
The Company has incurred significant losses from operations, and such losses are expected to continue. The Company's auditors have included a "Going Concern Qualification" in their report for the year ended December 31, 2008. In addition, the Company has limited working capital. The foregoing raises substantial doubt about the Company's ability to continue as a going concern. Management's plans include seeking additional capital and/or debt financing. There is no guarantee that additional capital and/or debt financing will be available when and to the extent required, or that if available, it will be on terms acceptable to the Company. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The "Going Concern Qualification" might make it substantially more difficult to raise capital.
ITEM 4. CONTROLS AND PROCEDURES.
Our management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 (the "Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the "SEC"), and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based closely on the definition of "disclosure controls and procedures" in Rule 15d-15(e) under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
At the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2009, the disclosure controls and procedures of our Company were effective to ensure that the information required to be disclosed in our Exchange Act reports was recorded, processed, summarized and reported on a timely basis.
-16-
--------------------------------------------------------------------------------
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There were no changes in internal controls over financial reporting that occurred during the quarter ended September 30, 2009, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
This report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.
-17-
--------------------------------------------------------------------------------
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The Company may be involved in legal actions and claims arising in the ordinary course of business from time to time, none of which at this time is considered to be material to the Company's business or financial condition.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During the three month period ended September 30, 2009, the Company sold 107,184,027 shares of its common stock for net cash proceeds of $2,588,353 in five private placements.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
ITEM 5. OTHER INFORMATION
None.
-18-
--------------------------------------------------------------------------------
ITEM 6. EXHIBITS
EXHIBIT NO. DESCRIPTION
----------------- -------------------------------------------------------------------------------------------
3.1 Articles of Incorporation(1)
3.2 Articles of Amendment dated October 25, 2001, June 24, 2002, and August 13, 2002(1)
3.3 Bylaws (1)
3.4 Certificate of Amendment dated September 30, 2003(2)
3.5 Certificate of Amendment dated October 25, 2001(3)
3.6 Certificate of Amendment June 24, 2002(3)
3.7 Certificate of Amendment August 13, 2002(3)
10.1 Patent #6,754,297(3)
10.2 Consulting Agreement(3)
10.3 Assignment(3)
10.6 Commercial Promissory Note dated August 4, 2004(4)
10.7 Security Agreement(4)
10.8 Commercial Promissory Note dated April 24, 2005(5)
10.9 Lease entered into May 24, 2001 by and between Dean M. Janes and Imaging Services, Inc.(6)
10.10 IR Commercial Real Estate Association Standard Industrial/Commercial Single-Tenant Lease -
Net, dated June 21, 2004 by and between Four T's, Bryan Tashjan, Ed Jr. Tashjan, Bruce
Tashjan, Greg Tashjan and Dean Janes DBA Imaging Services, Inc.(6)
31.1 Section 302 Certification of Chief Executive Officer
31.2 Section 302 Certification of Chief Financial Officer
32.1 Section 906 Certification
32.2 Section 906 Certification
-----------------
(1) Incorporated by reference to the Form 10-SB/A Registration
Statement filed with the Securities and Exchange Commissioner
on December 9, 2002.
(2) Incorporated by reference to Amendment #2 to Form SB-2
Registration Statement filed with the Securities and Exchange
Commission on October 6, 2004.
(3) Incorporated by reference to Amendment #3 to Form SB-2
Registration Statement filed with the Securities and Exchange
Commission on October 21, 2004.
(4) Incorporated by reference to Amendment #5 to Form SB-2
Registration Statement filed with the Securities and Exchange
Commission on April 18, 2005.
(5) Incorporated by reference to Amendment #6 to Form SB-2
Registration Statement filed with the Securities and Exchange
Commission on July 7, 2005.
(6) Incorporated by reference to Amendment #8 to Form SB-2
Registration Statement filed with the Securities and Exchange
Commission on September 9, 2005.
-19-
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 13, 2009 IMAGING3, INC.
By: /s/ Dean Janes
----------------------------------------
Dean Janes, Chief Executive Officer
and Chairman (Principal Executive Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: /s/ Dean Janes Dated: November 13, 2009
------------------------------------------------
Dean Janes, Chief Executive Officer
and Chairman (Principal Executive Officer)
By: /s/ Christopher Sohn Dated: November 13, 2009
------------------------------------------------
Christopher Sohn, President
and Chief Operating Officer
By: /s/ Xavier Aguilera Dated: November 13, 2009
------------------------------------------------
Xavier Aguilera, Director and Chief Financial
Officer, Secretary, and Executive Vice President
(Principal Financial/Accounting Officer)
-20-
U need to rush before it may get halted by the SEC
The Picture Gets Even Fuzzier at Imaging3
http://www.thestreetsweeper.org/
Hi,
My name is Dean Janes and I am the CEO of Imaging3. I am happy an investor board was created and I will make myself available to any questions by current and potential investors. My email address is dean@imaging3.com and our office number is 1-800-900-9729, my ext is 109. I will check in from time to time and try to be available to answer questions as much as possible online.
Sincererly,
Dean Janes, CEO Imaging3, Inc
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=10876149
Discrepancy with share count
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.
As of November 1, 2009, the number of shares outstanding of the registrant's class of common stock was 375,709,898.
------Filing Date: 11/13/2009 Form Type: 10-Q --------------------------------------------------------------------------
RECORD DATE AND VOTING
Stockholders of record at the close of business on November 2, 2009 (the "Record Date") are entitled to notice of and to vote at the Annual Meeting. As of the close of business on the Record Date, there were 323,361,552 shares of the Company's Common Stock (the "Common Stock") outstanding and entitled to vote. Each stockholder is entitled to one vote for each share of Common Stock held by such stockholder as of the Record Date.
Filing Date: 10/9/2009 Form Type: PRER14A
When i called today to Co TA http://mountainsharetransfer.com/ to find out what's the real # they said they are gagged by the co' and can't give out the info
co's that gagged TA are companies that keep diluting the shareholders and don't want investors to know that they keep printing stock so i will not be surprice if they are well above 400m o/s now[/b
A Small correction if i may
Shareholders meeting - they were trying to add additional directors beyond the current allowable. Also attempting to add to OS.
IMGG's lawyers sent out notice without SEC's approval and thus the meeting needed to be canceled. Dean felt that the meeting could be rescheduled in the next month or two.
the lawyers don't send out notice
the SEC didn't let the proxy go definitive
they gave them comments and are asking for more info that co' and it's lawyers couldn't satisfy the SEC from early October to date
When can we have another money TV?
Grate News NO FDA Rejection yet
LOL
For us all to find out later today
The Shareholder meeting requires SEC approval, which has not yet been received from the SEC at this time.
Why will the SEC not give them the approval to do the meeting ?
ANYBODY?
He said by the end of Nov
But didn't say Nov 2009
So maybe by the end of Nov 2010
I would sell first
and ask question later
after the CC you may find no buyers
NXTH & CLRH: Connected Like Siamese Twins
http://thestreetsweeper.org/undersurveillance.html?i=58
NXTH & CLRH: Connected Like Siamese Twins
http://thestreetsweeper.org/undersurveillance.html?i=58
The CC is instead of the SH meeting that the SEC didn't approve
JMHO
Can u explain me this part?
AMENDMENT TO ARTICLES OF INCORPORATION TO INCREASE AMOUNT
OF AUTHORIZED COMMON STOCK
As described in the accompanying NOTICE, the Company proposes to amend its Articles of Incorporation in order to increase the number of authorized shares of the Company's common stock from 500,000,000 to 750,000,000, par value $0.001 per share (the "Common Stock Articles Amendment"). As of November 2, 2009 and before the increase in authorized shares, 430,420,592 shares of the Company's common stock are not reserved for any specific use and are available for future issuance. As of November 2, 2009 and after the increase in authorized shares, 319,579,408 shares of the Company's common stock are not reserved for any specific use and are available for future issuance[/u[color=red]], except that the Company may set aside shares (currently estimated to be 16,000,000) [/color]to be authorized for a customary stock option plan for the Company's directors, officers, employees and key consultants in the future. The Company's Board of Directors has not yet adopted such a plan and is not certain when the plan will be adopted. If and when such a plan is adopted, the Company will then submit it to the shareholders for a vote to ratify it..
The Board of Directors of the Company voted unanimously to implement the Common Stock Articles Amendment because the Board of Directors believes that an increase to the number of authorized shares of the Company's common stock will allow the Company to raise part of the capital necessary for the Company to grow its business in the future.
http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=6835259
DJ IN THE MONEY: More Patience Asked Of Imaging3 Shareholders
By Carol S. Remond
A DOW JONES NEWSWIRES COLUMN
Patience is king when it comes to Imaging3 Inc. (IMGG).
First, there was the long-delayed, and still missing, clearance for commercialization by the U.S. Food and Drug Administration of Imaging3's Dominion medical scanner. Now, there is a postponing of Imaging3's shareholder meeting,
originally scheduled for Dec. 10, until next year.
Imaging3 Chief Executive Dean Janes wasn't immediately available to comment. But the wording of the company's press release Monday suggests that the U.S. Securities and Exchange Commission has yet to approve Imaging3's proxy statement.
Imaging3 said in the release that the shareholder meeting "requires SEC approval, which has not yet been received from the SEC at this time." While the SEC doesn't "approve" shareholder meetings, it does
review proxy statements and, on occasion, comments on them.
It does sound like the SEC might have had a number of comments with its comes to Imaging3's preliminary proxy statement filed on Oct. 9.
Meanwhile, shareholders are still awaiting FDA clearance of Imaging3's Dominion scanner.
CEO Janes first told investors on Oct. 29 his company might be cleared to market its mobile scanner by the end of November. Alas, November ended without FDA clearance announcement.
Janes' optimism led to huge spikes in Imaging3 stock price and trading volume. The stock, which topped at $1.95 a share on Nov. 13, closed Monday down 3.7%, at $1.21 a share. Imaging3 stock had been trading at around 5 cents until early September before online promotions started inviting investors to take a closer look at the
company.
Anxious shareholders might get some answers Wednesday when Janes, according to another company press release Monday, will update shareholders about a recent trade show he attended and "other recent developments important to the company and its Shareholders."
Stay tuned.
(Carol S. Remond, a special writer on the In The Money team, is an award-winning columnist who won a Gerald Loeb Award in 2005 for best news service content with "Exposing Small-Cap fraud," a series of articles that described how three small companies unscrupulously pumped up their stocks. She can be reached at 303-997-5783 or by
e-mail: carol.remond@dowjones.com)
No Way
Forget it
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON DECEMBER 10, 2009
DEAR STOCKHOLDER:
Notice is hereby given that the 2009 Annual Meeting of Stockholders ("Annual Meeting") of Imaging3, Inc. ("Imaging3" or the "Company") will be held at 10:00 a.m. Pacific Time, on Thursday, December 10, 2009 at 3200 W. Valhalla Drive, Burbank, California 91505.
At the Annual Meeting, you will be asked to consider and vote upon the following proposals:
1. An amendment to the Company's Articles of Incorporation in order to increase the number of authorized shares of common stock from 500,000,000, par value $0.001 per share, to 750,000,000, par value $0.001 per share, and to authorize 1,000,000 shares of preferred stock, par value $0.001 per share.
2. An amendment to the Company's Bylaws to increase the size of the Company's Board of Directors from two (2) to a range of five (5) to nine (9), with the exact number of directors to be seven (7).
3. Provided the amendment to the Company's Bylaws is adopted, the election of three members of the Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
If the amendment to the Company's Bylaws is not adopted, then the election of two members of the Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
4. Ratification of the appointment M&K CPAS, PLLC as Imaging3, Inc.'s ("Imaging3") independent registered public accounting firm for the fiscal year ending December 31, 2009.
5. The transaction of such other business and act upon any other matter which may properly come before the annual meeting or any adjournment or postponement of the meeting.
The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice.
The Board of Directors has fixed the close of business on November 2, 2009 as the record date for the determination of stockholders entitled to notice of and to vote at this 2009 Annual Meeting and at any adjournment or postponement thereof.
A copy of the Company's Form 10-K for the fiscal year ended December 31, 2008 is included with this proxy statement. A copy of the Annual Report and Proxy Statement can also be found on the Internet at www.imaging3.com.
Sincerely,
/s/ Dean Janes
Dean Janes
Chairman and Chief Executive Officer
IMPORTANT
PLEASE SIGN AND PROMPTLY RETURN THE ENCLOSED PROXY CARD IN THE ACCOMPANYING POSTAGE-PAID RETURN ENVELOPE SO THAT YOUR SHARES MAY BE VOTED IF YOU ARE UNABLE TO ATTEND THE ANNUAL MEETING.
--------------------------------------------------------------------------------
IMAGING3, INC.
3200 W. VALHALLA DRIVE
BURBANK, CALIFORNIA 91505
--------------------------------------------------------------------------------
PROPOSALS TO BE VOTED ON
PROPOSAL NO. 1
AMENDMENT TO ARTICLES OF INCORPORATION TO INCREASE AMOUNT
OF AUTHORIZED COMMON STOCK
As described in the accompanying NOTICE, the Company proposes to amend its Articles of Incorporation in order to increase the number of authorized shares of the Company's common stock from 500,000,000 to 750,000,000, par value $0.001 per share (the "Common Stock Articles Amendment"). As of November 2, 2009 and before the increase in authorized shares, 430,420,592 shares of the Company's common stock are not reserved for any specific use and are available for future issuance. As of November 2, 2009 and after the increase in authorized shares, 319,579,408 shares of the Company's common stock are not reserved for any specific use and are available for future issuance, except that the Company may set aside shares (currently estimated to be 16,000,000) to be authorized for a customary stock option plan for the Company's directors, officers, employees and key consultants in the future. The Company's Board of Directors has not yet adopted such a plan and is not certain when the plan will be adopted. If and when such a plan is adopted, the Company will then submit it to the shareholders for a vote to ratify it..
The Board of Directors of the Company voted unanimously to implement the Common Stock Articles Amendment because the Board of Directors believes that an increase to the number of authorized shares of the Company's common stock will allow the Company to raise part of the capital necessary for the Company to grow its business in the future.
The Company is not expected to experience a material tax consequence as a result of the Common Stock Articles Amendment. Increasing the number of authorized shares of the Company's common stock may, however, subject the Company's existing shareholders to future dilution of their ownership and voting power in the Company.
POTENTIAL ANTI-TAKEOVER EFFECT
The additional shares of common stock that would become available for issuance if the proposal were adopted could also be used by the Company to oppose a hostile takeover attempt or delay or prevent changes in control or management of the Company. For example, without further stockholder approval, the Board could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board. Although this proposal to increase the authorized common stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at the Company), nevertheless, stockholders should be aware that approval of this Proposal No. 1 could facilitate future efforts by the Company to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for their shares over then current market prices.
REQUIRED VOTE
Approval of the Common Stock Articles Amendment requires the affirmative "FOR" vote of a majority of the Votes Cast on the proposal. Unless marked to the contrary, proxies received will be voted "FOR" approval of the Common Stock Articles Amendment.
RECOMMENDATION
OUR BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE COMMON STOCK
ARTICLES AMENDMENT.
* * * * *
-3-
http://ih.advfn.com/p.php?pid=nmona&cb=1260074341&article=39837882&symbol=NB%5EIMGG
maybe another Money TV if we still have 17k in the bank
IMGG Investors Still Waiting for Judgment Day
http://www.thestreetsweeper.org/undersurveillance.html?i=57
U will get the same BS after 2009 RSNA as u got it in 2008
RSNA update, this has been the best show for us to date. I have met several times with most of the big OEM's, GE, Philips, Toshiba, Varian even Stryker flew out their entire Image Navigation team to meet with me. Physicians and Physicists have also expressed interest in the DViS and our stock. We have arranged several followup meetings with many of these OEM's as well. This is why RSNA is very important, not just for sales leads. This is from my cell, but I'll update you further this weekend.
RSNA update, this has been the best show for us to date. I have met several times with most of the big OEM's, GE, Philips, Toshiba, Varian even Stryker flew out their entire Image Navigation team to meet with me. Physicians and Physicists have also expressed interest in the DViS and our stock. We have arranged several followup meetings with many of these OEM's as well. This is why RSNA is very important, not just for sales leads. This is from my cell, but I'll update you further this weekend
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=33925117
Hw said that FDA will come in by the show